EXECUTIVE SUMMARY The University of Vermont College of Medicine and the Vermont
Lung Center, with support of the National Heart, Lung, and Blood Institute (NHLBI), the …

Macrophage migration inhibitory factor (MIF) is a pleiotropic proinflammatory cytokine that
has been implicated as playing a causative role in many disease states, including sepsis …

Mesenchymal stromal cells (MSCs) are inherently tumor homing and can be isolated,
expanded, and transduced, making them viable candidates for cell therapy. This tumor …

Human mesenchymal stem cells (MSCs) from bone marrow are a heterogeneous ensemble
of progenitors and lineage‐committed cells, with a broad range of regenerative properties …

Mesenchymal stem cells (MSCs) are able to home and migrate into damaged tissues and
are thus, considered an optimal therapeutic strategy for clinical use. We previously …

Cell‐to‐cell variation in the regenerative potential of mesenchymal stromal cells (MSCs)
impedes the translation of MSC therapies into clinical practice. Cellular heterogeneity is …

Abstract Background Mesenchymal stem cells (MSCs) are a mixture of progenitors that are
heterogeneous in their regenerative potential. Development of MSC therapies with …

The bone marrow-derived mesenchymal stem cells or mesenchymal stromal cells (MSCs),
with pluripotent differentiation capacity, present an ideal source for cell transplantation or …

Cellular heterogeneity of mesenchymal stem cells (MSCs) impedes their use in regenerative
medicine. The objective of this research is to identify potential biomarkers for the enrichment …

Exposure to high lethal dose of ionizing radiation results in acute radiation syndrome with
deleterious systemic effects to different organs. A primary target is the highly sensitive bone …